Effects of salvia miltiorrhiza injection on coagulation function of decompensated liver cirrhosis
Guo-Yong Hu,Juan Hu,Zhi-Gang Yan,Yan-Bing Ding,Jian Wu,Wei-Ming Xiao,Jian-Guo Yang
DOI: https://doi.org/10.11569/wcjd.v14.i32.3147
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To evaluate the effect of salvia miltiorrhiza (SM) injection on the coagulation function of patients with decompensated liver cirrhosis. METHODS: A total of 40 patients with decom- pensated liver cirrhosis were randomly and averagely divided into SM group and controls group. Besides comprehensive treatment, the patients in SM group also received SM injection for 2 wk. The indexes, including prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FIB) level were examined before and after treatment. Moreover, bleeding complication was observed in the two groups. RESULTS: Before treatment, the values of PT, APTT and TT, and the level of FIB were 17.2 ± 5.9 s, 50.3 ± 5.1 s, 21.5 ± 2.5 s, 1.7 ± 1.2 g/L incontrol group, and 17.5 ± 5.7 s, 50.1 ± 5.8 s, 21.3 ± 2.7 s, 1.7 ± 1.0 g/L in SM group, respectively. After treatment, the above markers were 15.8 ± 5.0 s, 47.2 ± 5.3 s, 19.2 ± 2.1 s, 1.8 ± 1.3 g/L in control group, and 14.5 ± 4.0 s, 44.2 ± 5.6 s, 17.2 ± 2.4 s, 2.0 ± 1.5 g/L in SM group, respectively. There were significant differences before and after treatment both in control group and SM group (P < 0.05), and furthermore, marked dif- ferences also existed between the two groups after treatment (P < 0.05). The incidence rate of bleeding complication was notably lower in SM group than that in control group (25% vs 50%, P < 0.05). CONCLUSION: SM injection can improve the coagulation function and lower the rate of bleeding complication in patients with de- compensated liver cirrhosis.